Cystic Fibrosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Request Brochure Request Discount

Report Code: ZMR-2895 | Report Format : | Status : Upcoming |


Cystic Fibrosis Therapeutics Market: Overview

Cystic fibrosis is an autosomal recessive and monogenetic disorder as a result of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR is a protein (transmembrane) that transports ions across the surface of epithelial cells. CFTR dysfunction affects a number of organs but lung disease is responsible for the majority of mortality in patients with cystic fibrosis.

CF is an autosomal recessive disease as a result of mutations in a gene located on chromosome 7. The CFTR is a single polypeptide protein containing 1480 amino acids that are observed to function both as a cyclic AMP-regulated, Cl- channel and as a regulator of other ion channels. The fully organized form of CFTR is found in the plasma membrane in normal epithelia. In a normal functioning cell, CFTR is synthesized in the rough endoplasmic reticulum (RER) followed by glycosylation in the Golgi apparatus and performing the function of a Cl- channel, and regulator of other ion channels when located in the plasma membrane. However, there can be two possible mutations in the CFTR gene, viz., (1) If a mutation disturbs protein folding, CFTR is degraded intracellularly thus, no protein is transported to the plasma membrane. (2) With other mutations, the abnormal protein is processed, reaches to the plasma membrane but functions abnormally at that site.

Cystic Fibrosis Therapeutics Market: Market Dynamics

The rising prevalence of Cystic Fibrosis (CF) globally, improved diagnostic technologies, growing investment in and awareness about genetic diseases, favorable initiatives undertaken by nonprofit organizations, development of the Healthcare industry and research and development activities undertaken by key players are expected to boost the market over the forecast period.

The market restraints include Cystic Fibrosis Related Complications, Increased Risk of Bacterial Infections in Cystic Fibrosis Patients, high cost involved in treatment and increase in complexity of the disease. Observed new opportunities in Cystic Fibrosis Therapeutic market include patent expiry of many innovator drug companies for Cystic Fibrosis leading to the introduction of generic drugs, Gene Therapy breakthrough for Cystic Fibrosis, a better understanding of the genetic structure which would help in innovating new drugs/therapies.

Segmentation based on Cystic Fibrosis therapeutic drug class:

Based on the therapeutic drug class the segmentation is Mucolytics, CFTR modulators, Pancreatic enzyme supplements and Bronchodilators.

Segmentation based on Cystic Fibrosis therapeutic route of administration:

Based on the route of drug administration, Oral drugs, and Inhaled drugs.

Segmentation based on regions:

North America leads the market for F.Y. 2016; as CF is most prevalent in North America due to the fact that most of the people affected with CF are of Caucasian descent, initiatives taken by Cystic Fibrosis Canada and CF Foundation are one of the key reasons that can be accounted for its largest share. Europe has the second-largest revenue share in global cystic fibrosis therapeutics, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. It is a rapidly growing segment in Asia-Pacific due to raising awareness about CF disorders & various treatment options. In addition, economic development in this region and improving healthcare facilities drive the market in this region.

Cystic Fibrosis Therapeutics Market: Competitors

Key manufacturers of Cystic Fibrosis Therapeutics include Hoffmann-La Roche Ltd, Gilead Sciences Inc, Merck & Co Inc, AbbVie Inc, Allergan plc, Alcresta Therapeutics Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, AstraZeneca Plc. among others

Cystic Fibrosis Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pharmaceutical Excipients Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3599.00 | Report Code: ZMR-2947 | Report Format:

Global Pharmaceutical Excipients Market: Overview An inactive substance, acting as a carrier with no medicinal properties that play a role in aiding characteristics which help in the formation of a tablet is known as excipients. It basically involves all the substance (except active pharmaceutic...Read More

Bipolar Disorder Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2940 | Report Format:

Global Bipolar Disorder Market: Overview Bipolar disorder is usually recognized as manic depression, it is a kind of mental illness which is mainly categorized by mood swings. Mood episodes are basically of two types: depressive and manic episodes. The changes or transformation in the mental con...Read More

Breakthrough Therapy (BT) Designation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2939 | Report Format:

Global Breakthrough Therapy (BT) Designation Market: Overview The breakthrough designation therapy is granted to medicines/drugs that bring about considerable betterment in syndrome conditions as compared to existing therapies at the time of preliminary stages of medical trials for the healing o...Read More

Hemophilia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2935 | Report Format:

Global Hemophilia Market: Overview Hemophilia is basically genetic bleeding syndrome caused owing to shortage or missing protein required for clotting, owing to which blood clotting does not take place. The episodes of bleeding majorly depend on the severity of hemophilia issue. There are two ma...Read More

Intravenous Immunoglobulin (IVIG) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2934 | Report Format:

Global Intravenous Immunoglobulin (IVIG) Market: Overview Immunoglobulins (IGs) are basically glycoproteins generated in the blood plasma in reaction to the antigens, which are entirely foreign to the host system. They are extremely complex entities as well as explicit in their action. They are ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.